Clinical Research Directory
Browse clinical research sites, groups, and studies.
PET-MR-PSA Prostate Cancer Recidive Study
Sponsor: Norwegian University of Science and Technology
Summary
Simultaneous PET/MRI has the potential to improve the detection accuracy in recurrent prostate cancer, since it combines the excellent soft-tissue contrast of MRI with the high molecular sensitivity of PET in a single imaging session. The aim of this study is to evaluate the sensitivity and specificity of simultaneous 18F-Fluciclovine PET/MRI for detection of recurrent prostate cancer.
Official title: 18F-Fluciclovine PET/MRI for Detection of Recurrent Prostate Cancer After Radical Treatment
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
80
Start Date
2015-09
Completion Date
2027-12
Last Updated
2025-06-06
Healthy Volunteers
No
Conditions
Locations (1)
St Olavs Hospital, PET center
Trondheim, Norway